Hwang JI, Chuang AH, Sidow SJ, McNally K, Goodin JL, McPherson JC 3rd. The effectiveness of endodontic solvents to remove endodontic sealers. Mil Med. 2015 Mar;180(3 Suppl):92-5.
Dinos ME, Borke JL, Swiec GD, McPherson JC 3rd, Goodin JL, Chuang AH. In vitro study of the adverse effect of nicotine and physical strain on human gingival fibroblasts as a model of the healing of wounds commonly found in the military. Mil Med. 2015 Mar;180(3 Suppl):86-91.
Lannan, F.M., D.K. O’conor, J.C. Broderick, J.F. Tate, J.T. Scoggin, N.A. Moran, C.M. Husson, E.M. Hegeman, C.E. Ogrydziak, S.A. Singh, A.G. Vafides, C.C. Brinkley, J.L. Goodin. Evaluation of Virulence Gene Expression Patterns in Acinetobacter baumannii Using Quantitative Real-Time Polymerase Chain Reaction Array. Under Review Military Medicine 2015.
Goodin JL, Pizarro-Matos JM, Prasad BM, Seiter TJ, Weaver CR, Muza SR, Beidleman BA, Wood JC. Hypoxia Response Gene Expression Patterns in Warfighters and Murine Populations. Accepted – In Press. Military Medicine 2013;178(11):1256-63
Goodin JL, BS Powell, JT Enama, RW Raab, RL McKown, GL Coffman, GP Andrews. Purification and characterization of a recombinant Yersinia pestis V-F1 “Reversed” fusion protein for use as a new subunit vaccine against plague. Protein Expr Purif. 2011 Mar;76(1):136-44.
U.S. Patent: Nellis, DF, Giardina, SL, and Goodin JL. Monodisperse and Modified Yersinia pestis Capsular F1-V Antigen Fusion Proteins for Vaccination Against Bubonic and Pneumonic Plague. Doc U.S. Patent Application No. 11/944,230 filed 21 Nov. 2008 (HHS Reference No. E-189-2007/0-US-01).
Goodin JL, Nellis DF, Powell BS, Vyas VV, Enama JT, Wang LC, Clark PK, Giardina SL, Adamovicz JJ, Michiel DF. Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague. Protein Expr Purif. 2007 May;53(1):63-79.
Swietnicki W, BS Powell, and JL Goodin. Yersinia pestis Yop translocation protein F: purification, characterization, and protective efficacy against bubonic plague. Protein Expr Purif. 2005 42:166-172.
Goodin JL, RW Raab, RL McKown, GL Coffman, BS Powell, JT Enama, JA Ligon, GP Andrews. Yersinia pestis outer membrane type III secretion protein YscC: expression, purification, characterization, and induction of specific antiserum. Protein Expr Purif. 2005. 40:152-163.
Raab, R. RL McKown, GL Coffman, and JL Goodin. Preliminary Report: Development of Recombinant Biological Vaccines and Critical Diagnostics to Address the Threat of Bioterrorism. In: Critical Infrastructure Protection Project. Workshop II Working Papers. Editors AR Woodcock and C Pommerening. George Mason University Press. 2004.
Goodin, JL & CL Rutherford. 2002 Isolation of differentially expressed genes during cAMP Induced NE differentiation in Human Prostate Cancer using mRNA Differential Display. Mol Carcinog. 2002. 33:88-98.
Goodin, JL & CL Rutherford. 2002. Characterization of human ribosomal S3a gene expression during cAMP induced neuroendocrine differentiation of LNCaP cells. Mol Biol Rep. 29:301-316.